COVID-19 transport and travel risks insights
Kennedys experts explore how COVID-19 is impacting on transport and travel.
Showing 1 - 10 of 23
On 26 February 2021, the Home Office launched a consultation into how the Government might use legislation to improve protective security and organisational preparedness at publicly accessible locations across the UK. The consultation seeks views from anyone who might be affected by a new “Protect Duty”, from individuals to businesses and public authorities. The consultation closes on 2 July 2021.
As the vaccination effort gains momentum, UK Government ministers are already setting targets for overseas travel. To date, over 30 million people in the UK have received the first dose of the vaccination resulting in calls for a ‘vaccine passport’ (or ‘COVID health certificate’), among others, to be implemented giving the travel industry a chance to begin its recovery process.
For some time, the regulatory framework applicable to cannabis products in Europe has been widely recognised as being particularly complex. As a result of this, companies frequently struggle with successfully navigating the regulatory regimes applicable in each country in which they sell. This looks set to continue as new UK requirements come into force on 1 April 2021.
The COVID-19 pandemic and Brexit have brought many challenges and changes to the way travel organisers have planned and operated their businesses over the past 12 months. Whilst the Brexit deadline for a deal has been and gone, its effects are still very much with us as businesses now need to work through the ramifications of the Trade and Cooperation Agreement (TCA) on their UK and overseas operations.
2021 promises to be a year dominated by evolution, transformation, and resilience. In this article we identify some of the key areas and issues that will have an impact upon the London marine market in 2021.
Our research identified five key risk themes that have implications and represent both challenges and opportunities for businesses, insurers, and wider society. This will assist in moving the conversation forward as we look beyond COVID-19, highlighting the important need to reshape the dynamic relationship between companies, households, and insurers.
In early December 2020, the UK government announced with considerable fanfare its approval of Pfizer/BioNTech’s COVID-19 vaccine. Around 40 million doses were ordered, and the UK’s mass vaccination programme commenced in December 2020, with the US, Canada, Bahrain and Saudi Arabia close behind. On 30 December 2020, the Oxford AstraZeneca vaccine received UK approval with the first doses administered in early January.
Almost one year on from the first reported case of the novel coronavirus in the Wuhan province of China, pensioner Margaret Keenan and intensive care unit nurse Sandra Lindsay, have now received the first vaccines in the UK and US respectively.
The aviation sector has been one of the most affected sectors due to the COVID-19 pandemic, suffering the biggest crisis in its history. Nevertheless, with the assistance of government measures and industry guidance, it seems that its slow recovery has started.
Historically, difficulties in proving a causal link between air pollution and poor health have kept at bay pollution related claims and governments’ accountability. However, this may be about to change.